General MedicationsORALGeneric
TERRAMYCIN
OXYTETRACYCLINE
Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview TERRAMYCIN is listed in Drugs@FDA under application 050287 (NDA).
Marketing status: Discontinued Active ingredient OXYTETRACYCLINE Form and strength TABLET;ORAL - 250MG Sponsor PFIZER Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview TERRAMYCIN is listed in Drugs@FDA under application 050287 (NDA). Marketing status: Discontinued Active ingredient OXYTETRACYCLINE Form and strength TABLET;ORAL - 250MG Sponsor PFIZER Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.